Yayun Chi
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 14
- RNA Research and Splicing 10
- Circular RNAs in diseases 8
- Ubiquitin and proteasome pathways 7
-
- Cancer-related molecular mechanisms research 15
- Cancer Genomics and Diagnostics 7
- Co-authors
- Jiong Wu (33 shared papers)Jingyan Xue (20 shared papers)Rong Guo (11 shared papers)Weiru Chi (18 shared papers)Sheng Huang (12 shared papers)Bingqiu Xiu (19 shared papers)Shenglin Huang (5 shared papers)Naisi Huang (5 shared papers)
- Journals
- Cancer Research (6 papers)Cancer Cell International (6 papers)Scientific Reports (4 papers)Journal of Translational Medicine (3 papers)Oncotarget (3 papers)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Yayun Chi
65 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 97
- Cancer Research 705
- Molecular Biology 1.0k
- Oncology 348
- Pathology and Forensic Medicine 158
- Cell Biology 94
Countries citing papers authored by Yayun Chi
This map shows the geographic impact of Yayun Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yayun Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yayun Chi more than expected).
Fields of papers citing papers by Yayun Chi
This network shows the impact of papers produced by Yayun Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yayun Chi. The network helps show where Yayun Chi may publish in the future.
Co-authors
The 25 scholars most cited alongside Yayun Chi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 169 | |
| 2 | 2015 | 113 | |
| 3 | 2015 | 97 | |
| 4 | 2016 | 90 | |
| 5 | 2007 | 61 | |
| 6 | 2020 | 50 | |
| 7 | Immunohistochemistry and microsatellite instability analysis in molecular subtyping of colorectal carcinoma based on mismatch repair competency. | 2015 | 46 |
| 8 | 2013 | 45 | |
| 9 | 2018 | 42 | |
| 10 | 2019 | 42 | |
| 11 | 2016 | 42 | |
| 12 | 2012 | 39 | |
| 13 | 2022 | 35 | |
| 14 | 2017 | 35 | |
| 15 | 2009 | 32 | |
| 16 | 2021 | 31 | |
| 17 | 2015 | 29 | |
| 18 | 2019 | 27 | |
| 19 | 2020 | 27 | |
| 20 | 2014 | 25 |
About Yayun Chi
Yayun Chi is a scholar working on Molecular Biology, Cancer Research, Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 67 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (15 papers), RNA modifications and cancer (14 papers), RNA Research and Splicing (10 papers), Cancer-related Molecular Pathways (9 papers), Circular RNAs in diseases (8 papers), Cancer Cells and Metastasis (7 papers), Cancer Genomics and Diagnostics (7 papers) and Ubiquitin and proteasome pathways (7 papers). The work is most often cited by research in Cancer Research (705 citations), Molecular Biology (1.0k citations), Oncology (348 citations), Pathology and Forensic Medicine (158 citations) and Cell Biology (94 citations). Yayun Chi has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Jiong Wu, Jingyan Xue, Rong Guo, Weiru Chi, Sheng Huang, Bingqiu Xiu, Shenglin Huang, Naisi Huang, Zhao‐Hui Wu and Ping Wei. Their work appears in journals such as Cancer Research, Cancer Cell International, Scientific Reports, Journal of Translational Medicine and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.